Algen Biotechnologies, Inc.
San Francisco, CA
- UEI
- LMQLCTBLR4M7
- CAGE
- 8CWW9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 665 3rd St #280, San Francisco, CA 94107, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Algenml: drug target discovery platform for transcriptional reprogramming of mycn-driven neuroblastoma project… | National Institute of General Medical Sciences (NIH) | $1,050,000 |
Quick answers
Is Algen Biotechnologies, Inc. registered in SAM.gov?
Yes. Algen Biotechnologies, Inc.'s SAM.gov registration is active through July 1, 2027.
What is Algen Biotechnologies, Inc.'s most recent federal award?
Algen Biotechnologies, Inc.'s most recent federal grant award is Algenml: drug target discovery platform for transcriptional reprogramming of mycn-driven neuroblastoma project… (R41GM146327), from National Institute of General Medical Sciences (NIH), on September 20, 2021.
On GovTribe
See Algen Biotechnologies, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors